A Novel Reporter Gene Assay for Pyrogen Detection

Area of Science:

• Biotechnology
• Immunology
• Cell Biology

Background:

• Fever results from a systemic inflammatory response to pyrogens.
• Nuclear factor κB (NF-κB) is a key signaling molecule in pyrogen-induced inflammation.
• Existing pyrogen detection methods may have limitations in spectrum or sensitivity.

Purpose of the Study:

• To develop and validate a novel reporter gene assay (RGA) for pyrogen detection.
• To utilize NF-κB reporter gene expression in RAW264.7 cells as a pyrogenic marker.
• To assess the sensitivity, accuracy, and applicability of the RGA across diverse pyrogens and molecules.

Main Methods:

• Established RAW264.7 cells stably transfected with an NF-κB reporter gene.
• Exposed cells to various pyrogens: lipopolysaccharide (LPS), lipoteichoic acid (LTA), and zymosan.
• Quantified NF-κB activity to establish dose-effect relationships and determine limits of detection (LOD).
• Validated the RGA's performance with diverse biological molecules and vaccine components.

Main Results:

• The RGA demonstrated a clear dose-effect relationship for NF-κB activity in response to pyrogens.
• Achieved low limits of detection: 0.03 EU/ml for LPS, 0.001 μg/ml for LTA, and 1 μg/ml for zymosan.
• Showcased broad applicability, successfully detecting pyrogens in various therapeutic proteins and vaccine formulations.
• Exhibited good precision and accuracy in pyrogen quantification.

Conclusions:

• The novel RGA is a feasible and effective tool for broad-spectrum pyrogen detection.
• The assay is sensitive, stable, and accurate, suitable for quality control in biopharmaceutical manufacturing.
• This reporter gene assay offers a valuable alternative for ensuring the safety of pharmaceutical products against pyrogenic contamination.